| Company/Division name | Mallinckrodt Pharmaceuticals |
| Parent company | Mallinckrodt Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2018 |
| Year reshoring implemented or to be implemented: | 2019 |
| Capital investment ($): | 20 |
| Country(ies) from which reshored: | Ireland |
| City reshored to: | St. Louis |
| State(s) reshored to: | MO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | acetaminophen and specialty drugs |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility |
